Key Takeaways
- 9,460 new melanoma cases are estimated in the U.S. in 2024 (with melanoma being a key UV-linked skin cancer type).
- 6.5% of basal cell carcinoma (BCC) cases and 10.2% of squamous cell carcinoma (SCC) cases are estimated to be attributable to indoor tanning.
- Tanning beds account for an estimated 419,000 cases of nonmelanoma skin cancer annually in the United States (including BCC and SCC).
- Approximately 10,000 melanoma cases each year are estimated to be attributable to indoor tanning in the United States.
- A cohort study reported that ever tanning bed use increased the risk of SCC (about 16% increase; directionally consistent across analyses).
- Estimated annual skin cancer deaths attributable to indoor tanning in the U.S. are about 154 (model estimate).
- In a U.S. survey, 33% of tanning device users believed tanning devices are safer than the sun (misperception prevalence).
- 12.6% of U.S. high school students reported using a tanning device in the past year (YRBS 2019, grades 9–12).
- 23% of U.S. young adults reported ever using an indoor tanning device (National Health Interview Survey estimate).
- In a U.S. study, indoor tanning prevalence was 7.7% among college students (within the study population).
- As of 2023, 18 states have enacted comprehensive indoor tanning bans or strict age limits (policy coverage).
- The FDA requires a warning label on tanning devices stating: “WARNING: Using this product can cause cancer.”
- The FDA recommends that individuals should not use tanning beds, particularly if under 18, and states that tanning bed use increases risk of skin cancer.
- 7.3% of U.S. adults reported indoor tanning use in the past year (National Health Interview Survey, 2020).
- Approximately 60% of observed tanning sessions in one U.S. field study used non-compliant or incomplete age-gating processes.
Indoor tanning drives substantial skin cancer harm in the US, including about 10,000 melanoma cases yearly.
Related reading
Disease Burden
Disease Burden Interpretation
Risk Attribution
Risk Attribution Interpretation
Evidence & Safety
Evidence & Safety Interpretation
Market Adoption
Market Adoption Interpretation
Regulation
Regulation Interpretation
More related reading
User Adoption
User Adoption Interpretation
Policy & Compliance
Policy & Compliance Interpretation
Market Size
Market Size Interpretation
Epidemiology & Risk
Epidemiology & Risk Interpretation
Burden & Costs
Burden & Costs Interpretation
How We Rate Confidence
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Margot Villeneuve. (2026, February 13). Tanning Bed Skin Cancer Statistics. Gitnux. https://gitnux.org/tanning-bed-skin-cancer-statistics
Margot Villeneuve. "Tanning Bed Skin Cancer Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/tanning-bed-skin-cancer-statistics.
Margot Villeneuve. 2026. "Tanning Bed Skin Cancer Statistics." Gitnux. https://gitnux.org/tanning-bed-skin-cancer-statistics.
References
- 1seer.cancer.gov/statfacts/html/melan.html
- 2onlinelibrary.wiley.com/doi/10.1002/ijc.30980
- 3jamanetwork.com/journals/jama/fullarticle/187472
- 25jamanetwork.com/journals/jamadermatology/fullarticle/2735706
- 4pubmed.ncbi.nlm.nih.gov/27216925/
- 5pubmed.ncbi.nlm.nih.gov/27813389/
- 6pubmed.ncbi.nlm.nih.gov/24510350/
- 10pubmed.ncbi.nlm.nih.gov/25292956/
- 11pubmed.ncbi.nlm.nih.gov/25647089/
- 12pubmed.ncbi.nlm.nih.gov/26778724/
- 14pubmed.ncbi.nlm.nih.gov/15955538/
- 17pubmed.ncbi.nlm.nih.gov/25963514/
- 7academic.oup.com/jnci/article/108/8/djw075/2466878
- 8cdc.gov/mmwr/volumes/67/wr/mm6704a1.htm
- 15cdc.gov/healthyyouth/data/yrbs/index.htm
- 9ncbi.nlm.nih.gov/pmc/articles/PMC4156413/
- 13ncbi.nlm.nih.gov/pmc/articles/PMC4354065/
- 16ncbi.nlm.nih.gov/pmc/articles/PMC4653571/
- 18ncbi.nlm.nih.gov/pmc/articles/PMC5459529/
- 19globenewswire.com/news-release/2024/02/15/2839326/0/en/Ultraviolet-Tanning-Systems-Market-Size-Share-Trends-Analysis-Report.html
- 20ncsl.org/health/skin-cancer-and-indoor-tanning
- 21fda.gov/radiation-emitting-products/tanning-devices-and-sunlamp-products
- 22fda.gov/news-events/press-announcements/fda-encourages-consumers-avoid-tanning-and-tanning-beds-and-sunlamp-products-skin-cancer-risk
- 23fda.gov/regulatory-information/search-fda-guidance-documents/requirements-labeling-and-safety-tanning-devices-and-sunlamp-products
- 24eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32006L0015
- 26tandfonline.com/doi/abs/10.1080/10872981.2020.1837829
- 27tandfonline.com/doi/full/10.1080/10872981.2018.1462145
- 28grandviewresearch.com/industry-analysis/indoor-tanning-salons-market
- 29sciencedirect.com/science/article/pii/S0002937822000309
- 31sciencedirect.com/science/article/pii/S1083520019303665
- 30link.springer.com/article/10.1007/s10198-019-01088-5







